Literature DB >> 11299243

Anesthetic inhibition in ischemic and nonischemic murine heart: comparison with conscious echocardiographic approach.

S Takuma1, K Suehiro, C Cardinale, T Hozumi, H Yano, J Shimizu, S Mullis-Jansson, R Sciacca, J Wang, D Burkhoff, M R Di Tullio, S Homma.   

Abstract

It is well known that the level of anesthesia obtained by intraperitoneal injection is variable and may alter cardiac function. In this study, we compared the effects of different anesthetics on cardiac function with the conscious state using high-resolution two-dimensional echocardiography in nonischemic and ischemic mice. Eighty-four mice were tested before and after surgery with ligation of the coronary artery. All 84 mice were studied in the conscious state and under high-dose intraperitoneal anesthesia. Twenty-two of 84 mice were studied under low-dose intraperitoneal anesthesia. Another 22 mice were also studied under gas anesthesia and spontaneous breathing. Experiments in the conscious state were performed by two investigators before the administration of anesthesia: one investigator held the animal and the transducer and the other operated the ultrasound equipment. Left ventricular systolic function was measured, and measurements obtained after surgery were compared with infarcted areas assessed by histological staining. Results showed that both high- and low-dose intraperitoneal anesthesia significantly reduced heart rates and left ventricular contractility in both pre- and postsurgical mice as opposed to conscious mice (P < 0.01). There were significantly higher correlation coefficients between mean fractional area change (FAC) and infarcted area in conscious state compared with high-dose intraperitoneal anesthesia (P < 0.05). The correlation coefficient between FAC and infarcted area during gas anesthesia was also significantly higher compared with high-dose intraperitoneal anesthesia (P < 0.05). In conclusion, conscious experiments or the use of gas anesthesia is preferred for echocardiographic assessment of cardiac function in mice because intraperitoneal injection significantly induces a significant reduction in heart rate and left ventricular systolic function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11299243     DOI: 10.1152/ajpheart.2001.280.5.H2364

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  12 in total

1.  Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice.

Authors:  Susan B Gurley; Alicia Allred; Thu H Le; Robert Griffiths; Lan Mao; Nisha Philip; Timothy A Haystead; Mary Donoghue; Roger E Breitbart; Susan L Acton; Howard A Rockman; Thomas M Coffman
Journal:  J Clin Invest       Date:  2006-07-27       Impact factor: 14.808

Review 2.  Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.

Authors:  Hans Erik Bøtker; Derek Hausenloy; Ioanna Andreadou; Salvatore Antonucci; Kerstin Boengler; Sean M Davidson; Soni Deshwal; Yvan Devaux; Fabio Di Lisa; Moises Di Sante; Panagiotis Efentakis; Saveria Femminò; David García-Dorado; Zoltán Giricz; Borja Ibanez; Efstathios Iliodromitis; Nina Kaludercic; Petra Kleinbongard; Markus Neuhäuser; Michel Ovize; Pasquale Pagliaro; Michael Rahbek-Schmidt; Marisol Ruiz-Meana; Klaus-Dieter Schlüter; Rainer Schulz; Andreas Skyschally; Catherine Wilder; Derek M Yellon; Peter Ferdinandy; Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2018-08-17       Impact factor: 17.165

3.  Cardiomyocyte lipids impair β-adrenergic receptor function via PKC activation.

Authors:  Konstantinos Drosatos; Kalyani G Bharadwaj; Anastasios Lymperopoulos; Shota Ikeda; Raffay Khan; Yunying Hu; Rajiv Agarwal; Shuiqing Yu; Hongfeng Jiang; Susan F Steinberg; William S Blaner; Walter J Koch; Ira J Goldberg
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-12-07       Impact factor: 4.310

4.  Inhibition of c-Jun-N-terminal kinase increases cardiac peroxisome proliferator-activated receptor alpha expression and fatty acid oxidation and prevents lipopolysaccharide-induced heart dysfunction.

Authors:  Konstantinos Drosatos; Zoi Drosatos-Tampakaki; Raffay Khan; Shunichi Homma; P Christian Schulze; Vassilis I Zannis; Ira J Goldberg
Journal:  J Biol Chem       Date:  2011-08-26       Impact factor: 5.157

5.  Image-based assessment of microvascular function and structure in collagen XV- and XVIII-deficient mice.

Authors:  C B Rygh; G Løkka; R Heljasvaara; T Taxt; T Pavlin; R Sormunen; T Pihlajaniemi; F R Curry; O Tenstad; R K Reed
Journal:  J Physiol       Date:  2013-11-11       Impact factor: 5.182

6.  Positive transcription elongation factor b activity in compensatory myocardial hypertrophy is regulated by cardiac lineage protein-1.

Authors:  Jorge Espinoza-Derout; Michael Wagner; Louis Salciccioli; Jason M Lazar; Sikha Bhaduri; Eduardo Mascareno; Brahim Chaqour; M A Q Siddiqui
Journal:  Circ Res       Date:  2009-05-14       Impact factor: 17.367

7.  Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction.

Authors:  Koichi Kaikita; Takanori Hayasaki; Toshiyuki Okuma; William A Kuziel; Hisao Ogawa; Motohiro Takeya
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

8.  Safety and efficacy of various combinations of injectable anesthetics in BALB/c mice.

Authors:  Sandra Buitrago; Thomas E Martin; Joanne Tetens-Woodring; Alan Belicha-Villanueva; Gregory E Wilding
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-01       Impact factor: 1.232

9.  Ceramide is a cardiotoxin in lipotoxic cardiomyopathy.

Authors:  Tae-Sik Park; Yunying Hu; Hye-Lim Noh; Konstantinos Drosatos; Kazue Okajima; Jonathan Buchanan; Joseph Tuinei; Shunichi Homma; Xian-Cheng Jiang; E Dale Abel; Ira J Goldberg
Journal:  J Lipid Res       Date:  2008-05-30       Impact factor: 5.922

10.  Regulation of plasma fructose and mortality in mice by the aldose reductase inhibitor lidorestat.

Authors:  Hye-Lim Noh; Yunying Hu; Tae-Sik Park; Thomas DiCioccio; Andrew J Nichols; Kazue Okajima; Shunichi Homma; Ira J Goldberg
Journal:  J Pharmacol Exp Ther       Date:  2008-10-30       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.